Nutex Health NASDAQ: NUTX held its annual meeting of stockholders virtually on April 23, 2026, with Chief Executive Officer and Chairman Dr. Thomas T. Vo presiding. The meeting focused on three voting proposals: the election of seven directors, a non-binding advisory vote on executive compensation, and ratification of Grant Thornton LLP as the company’s independent registered public accounting firm for the year ending Dec. 31, 2026.
Quorum and meeting procedures
Vo opened the meeting at 10:00 a.m. Central Time and introduced other directors and senior leaders in attendance, including President Dr. Warren Hosseinion, Chief Financial Officer Jon Bates, and Chief Operating Officer Elisa Luqman, who served as secretary of the meeting. Also present were outside corporate counsel Gisela Dannenberg of Troutman Pepper Locke and Jennifer Parker of Grant Thornton LLP.
The operator reported that 5,628,591 shares of common stock were outstanding and entitled to vote as of the Feb. 27, 2026 record date. According to the Inspector of Elections, at least 2,814,297 shares were represented virtually or by proxy, establishing a quorum and legally convening the meeting.
Vo noted that Paul R. Ramirez of American Election Services, LLC had been appointed as Inspector of Election and had sworn the oath.
Proposals presented to stockholders
The company put three proposals before stockholders, as described during the formal agenda:
- Proposal 1: Election of seven directors to serve until the 2027 annual meeting.
- Proposal 2: A non-binding advisory vote to approve compensation for the company’s named executive officers as disclosed in the proxy statement.
- Proposal 3: Ratification of Grant Thornton LLP as independent registered public accounting firm for the year ending Dec. 31, 2026.
Director nominees and voting process
For Proposal 1, the operator read a resolution to elect the following seven directors: Thomas T. Vo, Warren Hosseinion, Cheryl Grenas, Michael L. Reed, Scott J. Saunders, Kelvin Spears, and Frank E. Jaumot. Hosseinion moved to adopt the resolution and Bates seconded it.
For Proposal 2, the operator read a resolution to approve, in an advisory capacity, the compensation paid to the named executive officers as disclosed under SEC rules in the proxy statement. The motion and second were again made by Hosseinion and Bates, respectively.
For Proposal 3, the operator presented the resolution to ratify Grant Thornton LLP’s appointment as the company’s independent registered public accounting firm for the year ending Dec. 31, 2026. Hosseinion and Bates again provided the motion and second.
Vo said the polls opened at 10:08 a.m. Central Daylight Time and reminded stockholders they could vote online using the control number assigned by Broadridge and Transfer Online, Inc. He also noted that stockholders who had already voted by proxy did not need to vote again.
Vo stated that the definitive proxy statement and meeting notice were distributed commencing “on or about March 13th, 2026,” as evidenced by an affidavit of distribution by Broadridge, an authorized agent of Transfer Online, Inc. He also said the list of stockholders was available for inspection through the virtual meeting website during the meeting. With no motion to the contrary, the reading of the notice was waived.
Preliminary results and next steps
Vo declared the polls closed at 10:11 a.m. Central Daylight Time. Ramirez then reported preliminary voting results, stating that all three proposals were approved:
- Proposal 1 (Election of directors): Each nominee was approved by the affirmative vote of a plurality of voting power of shares present in person or by proxy and entitled to vote.
- Proposal 2 (Say-on-pay): Approved by the affirmative vote of a majority of voting power of shares present in person or by proxy and entitled to vote.
- Proposal 3 (Auditor ratification): Approved by the affirmative vote of a majority of voting power of shares present in person or by proxy and entitled to vote.
Vo said the final report of the Inspector of Election would be filed with the meeting records, and the company “expect[s] to report the results of the voting on a Form 8-K to be filed with the SEC within four business days of this meeting.”
With no further business, Hosseinion moved to adjourn and Bates seconded. The meeting was adjourned following an affirmative vote.
About Nutex Health NASDAQ: NUTX
Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nutex Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutex Health wasn't on the list.
While Nutex Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report